Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs for Duchenne Muscular Dystrophy (DMD) players cover Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, Italfarmaco, Santhera Pharmaceuticals and WaVe life Science, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Drugs for Duchenne Muscular Dystrophy (DMD) Industry Forecast” looks at past sales and reviews total world Drugs for Duchenne Muscular Dystrophy (DMD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs for Duchenne Muscular Dystrophy (DMD) sales for 2023 through 2029. With Drugs for Duchenne Muscular Dystrophy (DMD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Duchenne Muscular Dystrophy (DMD) industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Duchenne Muscular Dystrophy (DMD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Duchenne Muscular Dystrophy (DMD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Duchenne Muscular Dystrophy (DMD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Duchenne Muscular Dystrophy (DMD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Duchenne Muscular Dystrophy (DMD).
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Duchenne Muscular Dystrophy (DMD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs for Duchenne Muscular Dystrophy (DMD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs for Duchenne Muscular Dystrophy (DMD) players cover Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, Italfarmaco, Santhera Pharmaceuticals and WaVe life Science, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Drugs for Duchenne Muscular Dystrophy (DMD) Industry Forecast” looks at past sales and reviews total world Drugs for Duchenne Muscular Dystrophy (DMD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs for Duchenne Muscular Dystrophy (DMD) sales for 2023 through 2029. With Drugs for Duchenne Muscular Dystrophy (DMD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Duchenne Muscular Dystrophy (DMD) industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Duchenne Muscular Dystrophy (DMD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Duchenne Muscular Dystrophy (DMD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Duchenne Muscular Dystrophy (DMD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Duchenne Muscular Dystrophy (DMD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Duchenne Muscular Dystrophy (DMD).
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Duchenne Muscular Dystrophy (DMD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Eteplirsen
- Deflazacort
- Ataluren
- Hospitals
- Clinics
- Home Care
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sarepta Therapeutics
- PTC Therapeutics
- Pfizer
- Bristol-Myers Squibb
- Italfarmaco
- Santhera Pharmaceuticals
- WaVe life Science
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2029
2.1.2 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Type
2.2.1 Eteplirsen
2.2.2 Deflazacort
2.2.3 Ataluren
2.3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type
2.3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
2.4 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.5 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application
2.5.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
3 DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) MARKET SIZE BY PLAYER
3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Players
3.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2018-2023)
3.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) BY REGIONS
4.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions (2018-2023)
4.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023)
5.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
5.3 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023)
6.2 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
6.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Duchenne Muscular Dystrophy (DMD) by Country (2018-2023)
7.2 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
7.3 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) by Region (2018-2023)
8.2 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) MARKET FORECAST
10.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2024-2029)
10.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2024-2029)
10.1.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2024-2029)
10.2.1 United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.2 Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.3 Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.4 Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2024-2029)
10.3.1 China Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.2 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.3 Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.4 Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.5 India Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.6 Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2024-2029)
10.4.1 Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.2 France Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.3 UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.4 Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.5 Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2024-2029)
10.5.1 Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.2 South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.3 Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.4 Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.5 GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.6 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Type (2024-2029)
10.7 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.1.3 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 PTC Therapeutics
11.2.1 PTC Therapeutics Company Information
11.2.2 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.2.3 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 PTC Therapeutics Main Business Overview
11.2.5 PTC Therapeutics Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.3.3 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.4.3 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Italfarmaco
11.5.1 Italfarmaco Company Information
11.5.2 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.5.3 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Italfarmaco Main Business Overview
11.5.5 Italfarmaco Latest Developments
11.6 Santhera Pharmaceuticals
11.6.1 Santhera Pharmaceuticals Company Information
11.6.2 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.6.3 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Santhera Pharmaceuticals Main Business Overview
11.6.5 Santhera Pharmaceuticals Latest Developments
11.7 WaVe life Science
11.7.1 WaVe life Science Company Information
11.7.2 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.7.3 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 WaVe life Science Main Business Overview
11.7.5 WaVe life Science Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2029
2.1.2 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Type
2.2.1 Eteplirsen
2.2.2 Deflazacort
2.2.3 Ataluren
2.3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type
2.3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
2.4 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.5 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application
2.5.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
3 DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) MARKET SIZE BY PLAYER
3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Players
3.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2018-2023)
3.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) BY REGIONS
4.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions (2018-2023)
4.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023)
5.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
5.3 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023)
6.2 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
6.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Duchenne Muscular Dystrophy (DMD) by Country (2018-2023)
7.2 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
7.3 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) by Region (2018-2023)
8.2 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) MARKET FORECAST
10.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2024-2029)
10.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2024-2029)
10.1.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2024-2029)
10.2.1 United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.2 Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.3 Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.4 Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2024-2029)
10.3.1 China Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.2 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.3 Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.4 Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.5 India Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.6 Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2024-2029)
10.4.1 Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.2 France Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.3 UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.4 Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.5 Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2024-2029)
10.5.1 Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.2 South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.3 Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.4 Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.5 GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.6 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Type (2024-2029)
10.7 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.1.3 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 PTC Therapeutics
11.2.1 PTC Therapeutics Company Information
11.2.2 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.2.3 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 PTC Therapeutics Main Business Overview
11.2.5 PTC Therapeutics Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.3.3 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.4.3 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Italfarmaco
11.5.1 Italfarmaco Company Information
11.5.2 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.5.3 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Italfarmaco Main Business Overview
11.5.5 Italfarmaco Latest Developments
11.6 Santhera Pharmaceuticals
11.6.1 Santhera Pharmaceuticals Company Information
11.6.2 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.6.3 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Santhera Pharmaceuticals Main Business Overview
11.6.5 Santhera Pharmaceuticals Latest Developments
11.7 WaVe life Science
11.7.1 WaVe life Science Company Information
11.7.2 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.7.3 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 WaVe life Science Main Business Overview
11.7.5 WaVe life Science Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Eteplirsen
Table 3. Major Players of Deflazacort
Table 4. Major Players of Ataluren
Table 5. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 8. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 11. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player (2018-2023)
Table 13. Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
Table 14. Drugs for Duchenne Muscular Dystrophy (DMD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2018-2023)
Table 19. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2018-2023)
Table 23. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 25. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 27. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Table 29. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 31. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 33. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2018-2023)
Table 35. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 37. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 46. Key Market Challenges & Risks of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 47. Key Industry Trends of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 48. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Sarepta Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 53. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 54. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Sarepta Therapeutics Main Business
Table 56. Sarepta Therapeutics Latest Developments
Table 57. PTC Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 58. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 59. PTC Therapeutics Main Business
Table 60. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. PTC Therapeutics Latest Developments
Table 62. Pfizer Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 63. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Pfizer Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Italfarmaco Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 73. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 74. Italfarmaco Main Business
Table 75. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Italfarmaco Latest Developments
Table 77. Santhera Pharmaceuticals Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 78. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 79. Santhera Pharmaceuticals Main Business
Table 80. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Santhera Pharmaceuticals Latest Developments
Table 82. WaVe life Science Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 83. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 84. WaVe life Science Main Business
Table 85. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. WaVe life Science Latest Developments
Table 1. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Eteplirsen
Table 3. Major Players of Deflazacort
Table 4. Major Players of Ataluren
Table 5. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 8. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 11. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player (2018-2023)
Table 13. Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
Table 14. Drugs for Duchenne Muscular Dystrophy (DMD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2018-2023)
Table 19. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2018-2023)
Table 23. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 25. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 27. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Table 29. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 31. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 33. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2018-2023)
Table 35. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 37. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 46. Key Market Challenges & Risks of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 47. Key Industry Trends of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 48. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Sarepta Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 53. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 54. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Sarepta Therapeutics Main Business
Table 56. Sarepta Therapeutics Latest Developments
Table 57. PTC Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 58. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 59. PTC Therapeutics Main Business
Table 60. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. PTC Therapeutics Latest Developments
Table 62. Pfizer Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 63. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Pfizer Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Italfarmaco Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 73. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 74. Italfarmaco Main Business
Table 75. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Italfarmaco Latest Developments
Table 77. Santhera Pharmaceuticals Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 78. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 79. Santhera Pharmaceuticals Main Business
Table 80. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Santhera Pharmaceuticals Latest Developments
Table 82. WaVe life Science Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 83. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 84. WaVe life Science Main Business
Table 85. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. WaVe life Science Latest Developments
LIST OF FIGURES
Figure 1. Drugs for Duchenne Muscular Dystrophy (DMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country/Region (2022)
Figure 8. Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2022
Figure 10. Drugs for Duchenne Muscular Dystrophy (DMD) in Hospitals
Figure 11. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Drugs for Duchenne Muscular Dystrophy (DMD) in Clinics
Figure 13. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Drugs for Duchenne Muscular Dystrophy (DMD) in Home Care
Figure 15. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Home Care (2018-2023) & ($ Millions)
Figure 16. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2022
Figure 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player in 2022
Figure 18. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Value Market Share by Country in 2022
Figure 24. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region in 2022
Figure 29. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2022
Figure 30. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2022
Figure 31. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country in 2022
Figure 38. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 57. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 61. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 65. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 68. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 69. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 78. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Drugs for Duchenne Muscular Dystrophy (DMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country/Region (2022)
Figure 8. Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2022
Figure 10. Drugs for Duchenne Muscular Dystrophy (DMD) in Hospitals
Figure 11. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Drugs for Duchenne Muscular Dystrophy (DMD) in Clinics
Figure 13. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Drugs for Duchenne Muscular Dystrophy (DMD) in Home Care
Figure 15. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Home Care (2018-2023) & ($ Millions)
Figure 16. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2022
Figure 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player in 2022
Figure 18. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Value Market Share by Country in 2022
Figure 24. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region in 2022
Figure 29. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2022
Figure 30. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2022
Figure 31. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country in 2022
Figure 38. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 57. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 61. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 65. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 68. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 69. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2024-2029 ($ Millions)
Figure 78. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Application (2024-2029)
